Expression of a heterologous polypeptide in mammary tissue of transgenic non-human mammals using a long whey acidic protein promoter

• US 5,831,141 A
• Filed: 09/10/1992
• Issued: 11/03/1998
• Est. Priority Date: 01/11/1991
• Status: Expired due to Term

• Current Assignee: The American Red Cross, The United States of America As Represented By The Secretary of Agriculture, Virginia Tech Intellectual Properties, Inc. (Virginia Polytechnic Institute and State University)
• Original Assignee: United States Department Of Health And Human Services (Government of the United States of America), The American Red Cross
• Inventors: Hennighausen, Lother, Drohan, William N., Lubon, Henryk
• Primary Examiner(s): Crouch, Deborah
• Application Number:
  US07/943,246
• Time in Patent Office: 2,245 Days
• Field of Search: 800/2, 800/DIG. 1, 435/172.3, 435/69.1, 435/69.6, 435/320.1, 536/23.2, 536/24.1, 536/25.4, 935/9, 935/10, 935/6, 935/14, 935/19, 935/60, 935/64
• US Class Current: 800/7
• CPC Class Codes: A01K 2207/15 Humanized animals
• CPC Class Codes: A01K 2217/00 Genetically modified animals
• CPC Class Codes: A01K 2217/05 Animals comprising random inserted nucleic acids (transgenic)
• CPC Class Codes: A01K 2227/105 Murine
• CPC Class Codes: A01K 2227/108 Swine
• CPC Class Codes: A01K 2267/01 Animal expressing industrially exogenous proteins
• CPC Class Codes: A01K 67/0278 Knock-in vertebrates, e.g. humanised vertebrates
• CPC Class Codes: A61P 7/02 Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
• CPC Class Codes: C07K 2319/02 containing a signal sequence
• CPC Class Codes: C12N 15/8509 for producing genetically modified animals, e.g. transgenic
• CPC Class Codes: C12N 9/6464 Protein C (3.4.21.69)
• CPC Class Codes: C12Y 304/21069 Protein C activated (3.4.21.69)

Abstract

Heterologous polypeptides are produced in the milk of transgenic non-human mammals by the expression of a stably integrated DNA sequence containing the long whey acidic protein promoter operably linked to a DNA sequence encoding a heterologous polypeptide and a signal sequence. The transgenic non-human mammals of the present invention are produced by introducing this DNA sequence such that the DNA sequence is stably integrated into the DNA of germ line cells of the mature mammal and inherited in normal Mendelian fashion. A representative heterologous polypeptide is protein C.

Claims

1. A transgenic non-human mammal containing a DNA sequence stably integrated in its genome, wherein said exogenous DNA sequence comprises the 5'"'"' 4.2 kb Sau3A-Kpn1 promoter of the mouse whey acidic protein gene, operably linked to a DNA sequence encoding heterologous protein C and a signal peptide, wherein said whey acidic protein promoter is specifically active in mammary cells and said signal peptide is effective in directing the secretion of said protein C into the milk of said transgenic mammal, wherein the activated form of said secreted protein C has an enzymatic activity of at least 50% as plasma-derived protein C, and wherein said transgenic mammal is selected from the group consisting of mice, rats, rabbits, pigs, sheep, goats and cows.

2. The transgenic non-human mammal of claim 1, wherein said protein C is human protein C, and wherein said DNA sequence encoding protein C further comprises regulatory elements located in the non-coding regions of the human protein C gene, wherein said regulatory elements are the AUG start codon, donor and acceptor splice signals, the secretion peptide, translation termination signal, transcription termination signal, and polvadenylation signal.

3. The transgenic non-human mammal of claim 1, wherein said DNA sequence encoding human protein C comprises the human protein C gene from 21 basepairs upstream of the protein C start condon to the NehI site in the 3'"'"' end of the protein C gene.

4. The transgenic non-human mammal of claim 1, wherein said exogenous DNA sequence comprises a DNA sequence comprising the 5'"'"' 4.2 kb Sau3A-Kpn1 promoter fragment of the mouse whey acidic protein promoter ligated directly or by a linker to a fragment of the human protein C gene beginning 21 basepairs upstream of the protein C start codon and ending at the NheI site in the 3'"'"' end of the protein C gene.

5. A process for the production of heterologous protein C, comprising the steps of:

(A) providing a non-human transgenic mammal whose genome comprises a stably integrated DNA sequence comprising the 5'"'"' 4.2 kb Sau3A-Kpn1 promoter of the mouse whey acidic protein gene, operably linked to a DNA sequence encoding a heterologous protein C and a signal peptide, said promoter being specifically active in mammary cells and said signal peptide being effective in directing the secretion of said protein C into the milk of said transgenic mammal, and wherein said transgenic mammal is selected from the group consisting of mice, rats, rabbits, pigs, sheep, goats and cows;

(B) producing milk from said transgenic mammal, wherein said milk contains said secreted protein C, and wherein the activated form of said protein C has an enzymatic activity of at least 50% as plasma-derived protein C;

(C) collecting said milk; and

(D) isolating said protein C from said milk.

6. The process of claim 5, wherein said protein C is human protein C, and wherein said DNA sequence encoding protein C further comprises regulatory elements located in the non-coding regions of the human protein C gene, wherein said regulatory elements are the AUG start codon, donor and acceptor splice signals, the secretion peptide, translation termination signal, transcription termination signal, and polyadenylation signal.

7. The process of claim 5, wherein said DNA sequence encoding human protein C comprises the human protein C gene from 21 basepairs upstream of the protein C start codon to the NheI site in the 3'"'"' end of the protein C gene.

8. The process of claim 5, wherein said DNA comprises a DNA sequence comprising the 5'"'"' 4.2 kb Sau3A-Kpn1 promoter fragment of the mouse whey acidic protein promoter ligated directly or by a linker to a fragment of the human protein C gene beginning 21 basepairs upstream of the protein C start codon and ending at the NheI site in the 3'"'"' end of the protein C gene.

9. A process for producing non-human transgenic mammals, comprising the steps of (A) providing a mixture containing a double-stranded DNA;

(B) subjecting said mixture to anion-exchange high performance liquid chromatography to obtain purified double-stranded DNA; and

thereafter (C) microinjecting an aqueous buffer solution containing said purified double-stranded DNA into an animal embryo, wherein said double-stranded DNA is selected from the group consisting of a double-stranded DNA comprising the 5'"'"' 4.2 kb Sau3A-Kpn1 promoter fragment of the mouse whey acidic protein promoter, a double-stranded DNA comprising a fragment of the human protein C gene beginning 21 basepairs upstream of the protein C start codon and ending at the NheI site in the 3'"'"' end of the protein C gene, and a double-stranded DNA comprising a DNA sequence comprising the 5'"'"' 4.2 kb Sau3A-Kpn1 promoter fragment of the mouse whey acidic protein promoter ligated directly or by a linker to a fragment of the human protein C gene beginning 21 basepairs upstream of the protein C start codon and ending at the NheI site in the 3'"'"' end of the protein C gene, wherein the activated form of protein C encoded by said double-stranded DNA has an enzymatic activity of at least 50% as plasma-derived protein C, and wherein said transgenic mammal is selected from the group consisting of mice, rats, rabbits, pigs, sheep, goats and cows.

10. A transgenic non-human mammal containing a DNA sequence stably integrated in its genome, wherein said DNA sequence comprises the 5'"'"' 4.2 kb Sau3A-Kpn1 promoter fragment of the mouse whey acidic protein promoter, operably linked to a DNA sequence encoding a heterologous polypeptide whereby said polypeptide is expressed specifically in mammary cells of said transgenic mammal and said polypeptide comprises a signal peptide, said signal peptide being effective in directing the secretion of said polypeptide into the milk of said mammal.

11. The transgenic non-human mammal of claim 10, wherein said transgenic non-human mammal is selected from the group consisting of mice, rats, rabbits, pigs, sheep, goats and cows.

12. The mammal of claim 11, wherein said transgenic non-human mammal is sheep.

13. The mammal of claim 11, wherein said transgenic non-human mammal is a goat.

14. The mammal of claim 11, wherein said transgenic non-human mammal is a cow.

15. A process for the production of a heterologous polypeptide in the milk of a transgenic non-human mammal, comprising the steps of:

(A) providing a non-human transgenic mammal whose genome comprises a stably integrated DNA sequence comprising the 5'"'"' 4.2 kb Sau3A-Kpn1 promoter of the mouse whey acidic protein gene, operably linked to a DNA sequence encoding a heterologous polypeptide and a signal peptide, said promoter being specifically active in mammary cells and said signal peptide being effective in directing the secretion of said polypeptide into the milk of said transgenic mammal;

(B) producing milk from said transgenic mammal, wherein said milk contains said polypeptide;

(C) collecting said milk; and

(D) isolating said polypeptide from said milk.

16. The process of claim 15, wherein said transgenic non-human mammal is selected from the group consisting of mice, rats, rabbits, pigs, sheep, goats and cows.

17. The process of claim 16, wherein said transgenic non-human mammal is a sheep.

18. The process of claim 16, wherein said transgenic non-human mammal is a goat.

19. The process of claim 16, wherein said transgenic non-human mammal is a cow.

20. An isolated DNA molecule which regulates the expression of a heterologous gene, wherein said DNA molecule consists of the 5'"'"' 4.2 kb Sau3A-Kpn1 promoter of the mouse whey acidic protein gene.